Cholestasis with peripheral pulmonary stenosis
Cholestasis with peripheral pulmonary stenosis: Also known as arteriohepatic dysplasia or Alagille syndrome, this ia a genetic disorder characterized by yellowing of the skin (jaundice) in the newborn period, liver disease with cholestasis, peripheral pulmonic stenosis and unusual face. Children with Alagille syndrome usually present with jaundice (yellowing of the skin and whites of the eyes) in the newborn period. Cholestasis (stagnant flow of bile from the liver) then develops with puritis (itching), stools without the usual yellowing brown color, and enlargement of the liver and spleen. Peripheral pulmonic stenosis is a form of congenital heart disease (CHD). Other types of CHD also occur. The face has deep- set eyes, broad forehead, long nose with flat tip, prominence of the chin, and low-set or malformed ears. The outlook (prognosis) depends upon the degree of severity of the CHD and the liver disease (it can cause liver failure). The condition is an autosomal dominant trait meaning that the gene for it is on a non-sex chromosome (an autosome) and a single edition of the Alagille gene is sufficient to produce the disease. The gene has been discovered on chromosome 20 in band 20p12. The syndrome was first described by D. Alagille in the French medical literature in 1969.
Read Also:
- Cholesterol
The most common type of steroid in the body. Cholesterol has a reputation for being associated with an increased risk for heart and blood vessel disease. However, cholesterol is essential to the formation of bile acids, vitamin D, progesterone, estrogens (estradiol, estrone, estriol), androgens (androsterone, testosterone), mineralocorticoid hormones (aldosterone, corticosterone), and glucocorticoid hormones (cortisol). Cholesterol […]
- Cholesterol ester transfer protein
Cholesterol ester transfer protein: A protein that helps regulate the size of cholesterol particles and influence the process of atherogenesis (the formation of plaques in arteries). Abbreviated CETP. The CETP gene is in chromosome band 16q21. A number of mutations are known in the CETP gene. Some result in CEPT deficiency, increased levels of HDL […]
- Cholesterol guidelines
those with moderate risk (2 or more risk factors plus an under 10 percent risk of a heart attack in 10 years) or those with 0 to 1 risk factor. According to the report, the absolute benefits for people at the lower levels of risk are less clear cut and the recent clinical trials do […]
- Cholesterol lowering with fibrate
Cholesterol lowering with fibrate: The fibrates are cholesterol-lowering drugs that are primarily effective in lowering triglycerides and, to a lesser extent, in increasing HDL-cholesterol levels. Gemfibrozil (brand name: LOPID), the fibrate most widely used in the United States, can be very effective for patients with high triglyceride levels. However, it is not very effective for […]
- Cholesterol lowering with niacin
Cholesterol lowering with niacin: Niacin or nicotinic acid, one of the water-soluble B vitamins, improves all lipoproteins when given in doses well above the vitamin requirement. Nicotinic acid lowers the total cholesterol, “bad” LDL-cholesterol, and triglyceride levels, while raising the “good” HDL-cholesterol level. There are two types of nicotinic acid: immediate release and timed release. […]